Clinical trial
Vitamin D Deficiency, Insulin Resistance and FGF-23
NCT00491322 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00491322 |
|---|---|
| Title | Vitamin D Deficiency, Insulin Resistance and FGF-23 |
| Official title | Impact of Vitamin D Deficiency on Insulin Resistance and the Regulation of FGF-23 |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Vitamin D Deficiency |
| Intervention type | Dietary Supplement |
| Interventions | Ergocalciferol, Ergocalciferol placebo |
| Enrollment | 92 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Jun 26, 2007 |
| Last update posted | May 2, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: